» Articles » PMID: 29885797

Clinical Course and Pathogenicity of Variant Rabbit Haemorrhagic Disease Virus in Experimentally Infected Adult and Kit Rabbits: Significance Towards Control and Spread

Overview
Journal Vet Microbiol
Date 2018 Jun 11
PMID 29885797
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

RHDVb has become the dominant RHDV on the Iberian Peninsula. A better understanding of its pathogenicity is required to aid control measures. Thus, the clinical course, humoral immune response, viraemia and kinetics of RHDV-N11 (a Spanish RHDVb isolate) infection in different tissues at both viral RNA and protein levels were studied in experimentally infected young and adult rabbits. The case fatality rate differed between the two age groups, with 21% of kits succumbing while no deaths were observed in adults. Fever and viremia were strongly associated with death, which occurred 48 h post infection (PI) too fast for an effective humoral immune response to be mounted. A significant effect on the number of viral RNA copies with regard to the variables age, tissue and time PI (p < 0.0001 in all cases) was detected. Histological lesions in infected rabbits were consistently more frequent and severe in liver and spleen and additionally intestine in kits, these tissues containing the highest levels of viral RNA and protein. Although no adults showed lesions or virus antigen in intestine, both kits and adults maintained steady viral RNA levels from days 1 to 7 PI in this organ. Analysis revealed the fecal route as the main dissemination route of RHDV-N11. Subclinically infected rabbits had detectable viral RNA in their faeces for up to seven days and thus may play an important role spreading the virus. This study allows a better understanding of the transmission of this virus and improvement of the control strategies for this disease.

Citing Articles

Rabbit hemorrhagic disease virus 2, 2010-2023: a review of global detections and affected species.

Asin J, Calvete C, Uzal F, Crossley B, Duarte M, Henderson E J Vet Diagn Invest. 2024; 36(5):617-637.

PMID: 39344909 PMC: 11457751. DOI: 10.1177/10406387241260281.


Characterisation of GI-RHDVs (Rabbit Haemorrhagic Disease Viruses) in Terms of Their Pathogenicity and Immunogenicity.

Tokarz-Deptula B, Kulus J, Baraniecki L, Stosik M, Deptula W Int J Mol Sci. 2024; 25(10).

PMID: 38791380 PMC: 11120834. DOI: 10.3390/ijms25105342.


Neglected Spleen Transcriptional Profile Reveals Inflammatory Disorder Conferred by Rabbit Hemorrhagic Disease Virus 2 Infection.

Yu J, Li Y, Xiao L, Xie J, Guo Z, Ye Y Viruses. 2024; 16(4).

PMID: 38675838 PMC: 11054208. DOI: 10.3390/v16040495.


Optimising the Delivery of RHDV to Rabbits for Biocontrol: An Experimental Evaluation of Two Novel Methods of Virus Delivery.

Dorji T, Jayasingha Ellakkala Appuhamilage R, Bird P, Huang N, OConnor T, Patel K Viruses. 2023; 15(9).

PMID: 37766220 PMC: 10536075. DOI: 10.3390/v15091814.


Digital PCR (dPCR) Quantification of miR-155-5p as a Potential Candidate for a Tissue Biomarker of Inflammation in Rabbits Infected with /Rabbit Hemorrhagic Disease Virus (RHDV).

Hukowska-Szematowicz B, Ostrycharz E, Dudzinska W, Roszkowska P, Siennicka A, Wojciechowska-Koszko I Viruses. 2023; 15(7).

PMID: 37515264 PMC: 10386091. DOI: 10.3390/v15071578.